Orbimed Advisors - DURATA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of DURATA THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$22,643,000
-25.5%
1,785,7140.0%0.24%
-33.6%
Q2 2014$30,411,000
+26.5%
1,785,7140.0%0.36%
+20.6%
Q1 2014$24,046,000
+5.3%
1,785,7140.0%0.30%
-11.9%
Q4 2013$22,839,000
+41.5%
1,785,7140.0%0.34%
+16.7%
Q3 2013$16,143,000
+25.6%
1,785,7140.0%0.29%
+5.5%
Q2 2013$12,857,0001,785,7140.27%
Other shareholders
DURATA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Canaan Partners VII LLC 1,902,030$24,118,00041.13%
Aisling Capital LLC 2,030,175$25,740,0004.99%
EAM Investors, LLC 187,925$2,383,0000.48%
Granahan Investment Management 691,283$8,765,0000.27%
Orbimed Advisors 1,785,714$22,643,0000.24%
Lenox Wealth Advisors, LLC 11,000$139,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 76,150$966,0000.02%
PDT Partners, LLC 61,331$778,0000.02%
MAGEE THOMSON INVESTMENT PARTNERS LLC 5,022$63,0000.02%
MASON STREET ADVISORS, LLC 148,533$1,883,0000.02%
View complete list of DURATA THERAPEUTICS INC shareholders